May 12, 2017 — The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their…Original Article
FDA Authorizes Use of New Device to Treat Esophageal Birth Defect in Babies
